skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8847

Comorbidity and glycemia control among patients with type 2 diabetes in primary care

Original Research

(5260) Views  (1123) Full article downloads

Authors: Catherine Hudon, Martin Fortin, Marie-France Dubois, José Almirall

Published Date November 2008 Volume 2008:1 Pages 33 - 37
DOI: http://dx.doi.org/10.2147/DMSO.S4193

Catherine Hudon1,3, Martin Fortin1,3, Marie-France Dubois2, José Almirall3

1Department of Family Medicine, 2Department of Community Health Sciences, Sherbrooke University, Sherbrooke, Quebec, Canada; 3Centre de Santé et de Services Sociaux de Chicoutimi, Quebec, Canada

Abstract: Reports on the relationship between comorbidity and glycemia control in diabetic patients are conflicting and the method of measuring comorbidity varies widely among studies. The aim of the present study was to evaluate the relationship between diabetes control and comorbidity, taking into account all comorbidities and their severity, in a primary care setting. We performed a retrospective descriptive study based on chart review of 96 randomly selected type 2 diabetic patients. Comorbidity was measured with the cumulative illness rating scale (CIRS), an exhaustive comorbidity index. Diabetes was considered as controlled if the mean value of two measurements of glycosylated hemoglobin A (HbA1c) was less than 7%. Taking diabetes control as the dependent variable, its relationship with the CIRS score, age, sex, diabetes duration, and diabetes-related complications was explored. Diabetes control was not significantly related with the CIRS score, age, sex or diabetes severity. Diabetes duration was the only variable significantly related to diabetes control. Our study suggests that comorbidity measured with the CIRS in patients with type 2 diabetes is not a factor that prevents the achievement of a good glycemia control.

Keywords: glycemia control, type 2 diabetes mellitus, comorbidity, primary care








Readers of this article also read:

Analog insulin detemir for patients with type 1 and type 2 diabetes: a review
Self-monitoring of blood glucose in noninsulin-treated type 2 diabetes: an overview
Minimizing the risk of hypoglycemia in patients with type 2 diabetes mellitus
Risk factors associated with metabolic syndrome in type 2 diabetes mellitus patients according to World Health Organization, Third Report National Cholesterol Education Program, and International Diabetes Federation definitions
Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach
Management of diabetes across the course of disease: minimizing obesity-associated complications
Clinical and behavioral factors associated with management outcome in hospitalized patients with diabetic foot ulcer
Insulin detemir for the treatment of obese patients with type 2 diabetes
Obesity: considerations about etiology, metabolism, and the use of experimental models
Clinical features and treatment of maturity onset diabetes of the young (MODY)
  • Testimonials

    "You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio